ライフサイエンスコーパス: galactosyl

1 hydroxyl group of galactosyl residue of beta-galactosyl 1-->1 sphingosine (psychosine).

2 yme glucosyltransferase UDP galactose:beta-D-galactosyl-1, 4-N-acetyl-D-glucosaminide alpha(1-3)galac

3 rase uridine 5'-diphosphate galactose:beta-D-galactosyl-1, 4-N-acetyl-D-glucosaminide alpha(1-3)galac

4 L5), and (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyl

5 ase, ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha2,6-sialylt

6 cribe the cloning of a UDP-galactose: beta-d-galactosyl-1,4-glucosylceramide alpha-1, 3-galactosyltra

7 nthesized by the enzyme UDP galactose:beta-D-galactosyl-1,4-N-acetyl-D-glucosaminide alpha(1-3)galact

8 d to be an AGP by precipitation with (beta-D-galactosyl)3 Yariv phenylglycoside and by amino acid com

9 (beta-D-glucosyl)3 and (beta-D-galactosyl)3 Yariv phenylglycosides, commonly known as Y

10 Here (beta-D-galactosyl)3 Yariv reagent was added to Arabidopsis thal

11 ARSA) activity toward the natural substrate, galactosyl-3-sulfate ceramide (or sulfatide), is perform

12 n substrate binding by directly ligating the galactosyl 6-hydroxyl.

13 ring structure is additionally modified by a galactosyl-, a mannosyl-, or a glutamyl-residue.

14 ave abundant circulating anti-alpha (1,3-di)-galactosyl (alpha Gal) antibodies (anti-Gal).

15 tibodies are primarily directed to alpha-1,3-galactosyl (alpha Gal) residues on endothelial cell surf

16 nating tumor cell membranes to express alpha-galactosyl (alpha-gal) epitopes (i.e., Galalpha1,3Galbet

17 e mammalian species contain the disaccharide galactosyl-alpha-(1,3)-galactose (alpha-Gal).

18 The presence of the nonhuman galactosyl-alpha-(1,3)-galactose (Gal-alpha-(1,3)-Gal) c

19 ferase (alpha3GT) catalyzes the synthesis of galactosyl-alpha-1,3-beta-galactosyl structures in mamma

20 ediated through preformed antibodies against galactosyl-alpha-1,3-galactose (Galalpha-1,3-Gal) epitop

21 which were produced by cell lines expressing galactosyl(alpha1-3)galactosyl (alphaGal) sugars, were f

22 rom alphaGal-negative cells, indicating that galactosyl(alpha1-3)galactosylation sensitizes these vir

23 UDP-galactose:beta-galactosyl-alpha1,3-galactosyltransferase (alpha3GT) cat

24 r lysosomal processing of a precursor lipid, galactosyl-(alpha1-2)-galactosyl ceramide.

25 ve prepared in baboons high titer anti-alpha-Galactosyl (alphaGal) and anti-porcine aortic endothelia

26 ted by the interaction of natural anti-alpha-galactosyl (alphaGal) antibodies with alphaGal epitopes

27 ntibodies (NAbs) against a terminal alpha1-3 galactosyl (alphaGal) epitope have been identified as th

28 by cell lines expressing galactosyl(alpha1-3)galactosyl (alphaGal) sugars, were found to be less stab

29 We report several classes of galactosyl analogues with varied substitution at the ano

30 s (Arabidopsis thaliana) XyG, which contains galactosyl and fucosyl substituents, tomato (Solanum lyc

31 erts a strong alpha-directing effect in both galactosyl and glucosyl donors, irrespective of the conf

32 to be to provide for the interconversion of galactosyl and glucosyl groups.

33 Glycolipids containing alpha-linked galactosyl and glucosyl moieties have been shown to poss

34 entropy change of binding of the two groups (galactosyl and glucosyl) of oligosaccharides to the two

35 -exposed N-acetylneuraminyl, alpha- and beta-galactosyl, and N-acetylhexosaminyl sugars from human an

36 Conditions for demonstrating efficient galactosyl- and distal Kdo-transferase activities are no

37 residues become glycosylated in the form of galactosyl- and glucosylgalactosyl-hydroxylysine.

38 ion of these rice genes, including fucosyl-, galactosyl-, and acetyltransferases, in the correspondin

39 ecting donor animals with monoreactive alpha-galactosyl antibodies before transplantation.

40 of renal fibroblasts with baboon anti-alpha-Galactosyl antibodies resulted in increased synthesis of

41 etic factors that shape the human anti-alpha-galactosyl antibody response, and provide a framework fo

42 No sensitization of alpha-galactosyl antibody responses was observed.

43 4,6-O-Benzylidene-alpha-d-galactosyl azide crystallizes into two morphologically d

44 ere synthesized using a 4,6-O-DTBS protected galactosyl azide donor.

45 3), (G(M3), N-acetylneuraminosyl-alpha(2, 3)-galactosyl-beta(1,4)-glucosylceramide), were inactive in

46 oteins generated glycoproteins with terminal galactosyl-beta-1, 4-GlcNAc and thus permitted their iso

47 The glycosphingolipid, psychosine (d-galactosyl-beta-1,1' sphingosine), accumulates to microm

48 harness endogenous anti-galactose-alpha-1,3-galactosyl-beta-1,4-N-acetyl-glucosamine (anti-alphaGal)

49 sy), glucosyl-beta1'1-sphingosine (Glu-Sph), galactosyl-beta1'1-ceramide (Gal-Cer), or lactosyl-beta1

50 ation of the major xenogeneic antigen, alpha-galactosyl, by injecting donor animals with monoreactive

51 ta 1,4GlcNAc beta 1, 4GlcNAc) and an alpha 3-galactosyl-capped trisaccharide (Gal alpha 1,3Gal beta 1

52 In contrast, a beta 4-galactosyl-capped trisaccharide (Gal beta 1,4GlcNAc beta

53 y high affinity) site binds both the alpha 3-galactosyl-capped trisaccharide and the two fucosylated

54 w affinity) site binds a nonfucosylated beta-galactosyl-capped trisaccharide.

55 The unchanged levels of galactosyl ceramidase, i.e., the enzyme lacking in Krabb

56 GLD patients who lack the degradative enzyme galactosyl ceramidase.

57 Galactosyl-ceramidase (GALC) is a ubiquitous lysosomal e

58 Keratinocytes loaded with alpha-galactosyl ceramide (alpha-GalCer) could stimulate IFN-g

59 They react to the glycolipid alpha-galactosyl ceramide (alpha-GalCer) presented by CD1d, an

60 her species can present the glycolipid alpha-galactosyl ceramide (alpha-GalCer) to mouse natural kill

61 ll responses to the glycolipid antigen alpha-galactosyl ceramide (alpha-GalCer) were dampened by prio

62 ogs of the well known NKT cell agonist alpha-galactosyl ceramide (alpha-GalCer), bacterial glycolipid

63 ion with the NKT cell-specific agonist alpha-galactosyl ceramide (alphaGC), Sh2d1a-/- splenocytes did

64 IV-1 receptor proteins CD4, CCR5, CXCR4, and galactosyl ceramide (GalCer).

65 ctin binds sulfated proteoglycan, 3-sulfated galactosyl ceramide (sulfatide), and heparin.

66 using the previously cloned cDNA encoding a galactosyl ceramide 3-O-sulfotransferase, which we term

67 the CD1d molecule to bind and present alpha-galactosyl ceramide after lysosomal processing of a prec

68 in response to the model iNKT cell Ag alpha-galactosyl ceramide and expressed lower amounts of the T

69 ted with the NKT cell-specific agonist alpha-galactosyl ceramide and its analog PBS57.

70 simple strategy for the synthesis of beta-C-galactosyl ceramide and its new aza-variant analogue is

71 le for assembly or the ability to bind alpha-galactosyl ceramide and to present it to human NKT cells

72 Cell surface expression was detected for galactosyl ceramide but not for CC-chemokine receptor 5,

73 uding NKT cells not reactive with CD1d-alpha-galactosyl ceramide complexes.

74 The preparation of the glycosphingolipid galactosyl ceramide from an orthogonally protected five-

75 Alpha-galactosyl ceramide has been identified to be a potent s

76 By contrast, alpha-galactosyl ceramide induced cytokine secretion is depend

77 A beta-C-galactosyl ceramide was synthesized in a stereoselective

78 1) and recognize lipid antigens (e.g., alpha-galactosyl ceramide) presented by nonpolymorphic CD1 mol

79 Galactosyl ceramide, a glycosphingolipid, has been postu

80 ugh both Gal3ST-2 and Gal3ST-3 do not act on galactosyl ceramide, Gal3ST-3 is only moderately more ho

81 er T (NKT) cells mobilizing glycolipid alpha-galactosyl ceramide, used to mature splenic DCs, served

82 ion factor 21 and GATA3 expression and alpha-galactosyl ceramide-induced cytokine production in vivo.

83 levels of IL-4 following TCR ligation, alpha-galactosyl ceramide-stimulated NKT cells from the livers

84 bes a short and efficient synthesis of alpha-galactosyl ceramide.

85 ns (MLR), anti-CD3, and the glycolipid alpha-galactosyl ceramide.

86 osphingolipid, or a synthetic agonist, alpha-galactosyl ceramide.

87 aired following in vivo challenge with alpha-galactosyl ceramide.

88 of a precursor lipid, galactosyl-(alpha1-2)-galactosyl ceramide.

89 aded with a synthetic NKT cell ligand, alpha-galactosyl-ceramide (alpha-GalCer; KRN-7000) in five pat

90 into oligomers that were capable of binding galactosyl-ceramide and G(M1) gangliosides.

91 In vivo stimulation of iNKT cells by alpha-galactosyl-ceramide was effective in both preventing and

92 nistration of concanavalin A (ConA) or alpha-galactosyl-ceramide, which induce liver inflammation and

93 Additionally, the synthesis of the 2-azido-galactosyl chloride donor was optimized into a three-ste

94 ployed a silver oxide for coupling a 2-azido-galactosyl chloride donor with two acceptors, Fmoc-Ser/T

95 s and glycosidation of differently protected galactosyl chlorides.

96 digestion indicated that the majority of the galactosyl component was in the furanoic conformation (b

97 l other genes in the biosynthetic pathway of galactosyl-containing complex oligosaccharides were more

98 exo-galactanase levels and the highest wall galactosyl content during the early stages of ripening,

99 Total cell wall galactosyl contents in the antisense fruit were not sign

100 This strategy has allowed us to identify the galactosyl derivative 14a, as an interesting hit exhibit

101 Interestingly, this galactosyl derivative has shown marked selective cytotox

102 as diminished with a concomitant increase in galactosyl-DHLNL.

103 rthermore, in the Borrelia burgdorferi alpha-galactosyl diacylglycerol-CD1d complex, TCR binding caus

104 3,6-anhydro-bridge or a suitable 3,6-anhydro-galactosyl donor to form the unfavored 1,2-cis-equatoria

105 elds of the glycosylations using fluorinated galactosyl donors indicated that the fluorine modificati

106 It was found that esters on O-6 of galactosyl donors of the phenyl thioglycoside type had a

107 In galactosyl donors, the 6-O-benzoyl group alone favored b

108 di-O-benzoyl, and 4,6-di-O-benzoyl protected galactosyl donors, with the highly electron-withdrawing

109 osyl acceptors with differentially protected galactosyl donors.

110 of anionic nucleophiles toward the covalent galactosyl-enzyme intermediate of the reactions catalyze

111 trophenyl beta-D-galactopyranoside through a galactosyl-enzyme intermediate that shows a high reactiv

112 everse of the reaction of azide ion with the galactosyl-enzyme intermediate.

113 f the beta-D-galactopyranosyl group from the galactosyl-enzyme intermediates of the galactosyl transf

114 catalysis of the reaction of water with the galactosyl-enzyme intermediates.

115 d GlcSph from the far more abundant isobaric galactosyl epimers naturally occurring in white matter.

116 Anti-Gal interacts with the alpha-galactosyl epitope (Ga1alpha1-3Galbeta1-4GlcNAc-R), whic

117 The synthetic free alpha-galactosyl epitope (Gal alpha1-3Gal beta1-4GlcNAc) was f

118 saged through these cells acquired the alpha-galactosyl epitope in association with the envelope glyc

119 se data suggest that expression of the alpha-galactosyl epitope on the surface of viruses may have im

120 -78 cells expressed high levels of the alpha-galactosyl epitope on their membrane surface, rendering

121 This carbohydrate structure (the alpha-galactosyl epitope) is expressed on the cells of most ma

122 t, like other retroviruses bearing the alpha-galactosyl epitope, HIV modified to express this epitope

123 nthetic disaccharide that contains the alpha-galactosyl epitope, indicating that virolysis is mediate

124 s that were manipulated to express the alpha-galactosyl epitope.

125 rase responsible for generation of the alpha-galactosyl epitope.

126 ten-fold less effective than the free alpha-galactosyl epitope.

127 Human immunity to alpha(1,3)Galactosyl epitopes (alpha Gal) may provide the means fo

128 ng natural antibodies recognizing alpha(1,3)-galactosyl epitopes (alphaGal) not present on human cell

129 e found to express very low amounts of alpha-galactosyl epitopes (Gal alpha1-3Gal beta1-4GlcNAc-R).

130 esulted in synthesis and expression of alpha-galactosyl epitopes (Gal(alpha)1-3Gal(beta)1-4GlcNAc-R)

131 nti-Gal antibody, which interacts with alpha-galactosyl epitopes (i.e., Gal alpha1-3Gal beta1-4GlcNAc

132 e carbohydrates, such as appearance of alpha-galactosyl epitopes as a result of up-regulation of the

133 d, as measured in ELISA with synthetic alpha-galactosyl epitopes linked to bovine serum albumin or wi

134 It is suggested that synthesis of alpha-galactosyl epitopes on freshly isolated human tumor cell

135 e immune system responds vigorously to alpha-galactosyl epitopes on xenografts by activating many B l

136 alpha-Galactosyl epitopes were synthesized in vitro on human t

137 if these cells express low numbers of alpha-galactosyl epitopes.

138 igosaccharides (RFOs, which are alpha-(1->6)-galactosyl extensions of sucrose).

139 selective, but more beta-selective using the galactosyl fluoride and depending on the acceptor used.

140 e evidences towards the higher resistance of galactosyl-fructose linkages during its intestinal degra

141 rate that different heterologously expressed galactosyl-, fucosyl-, and xylosyltransferases can trans

142 human Ig is due to natural Abs specific for galactosyl (Gal)alpha1-3Gal.

143 yl galactosyl globoside (SGG) and disialosyl galactosyl globoside (DSGG), which specifically bound ur

144 only to GM1 and asialo-GM1 (Gg4) but also to galactosyl globoside (Gb5) as well.

145 ress two extended globoseries GSLs, sialosyl galactosyl globoside (SGG) and disialosyl galactosyl glo

146 od group-related glycosphingolipid, sialosyl galactosyl globoside (SGG), has recently been implicated

147 lysaccharide components with a wide range of galactosyl, glucosyl and mannosyl linkages that do not d

148 ular protein that catalyzes the formation of galactosyl-glucosyl-diacylglycerol, a glycolipid importa

149 glycosyltransferases in other families with galactosyl-, glucosyl-, and xylosyltransferase activitie

150 hermophilus T-1 can also utilize lactose and galactosyl-glycerol via the cellobiose-PTS system togeth

151 esence of cellobiose, with either lactose or galactosyl-glycerol, revealed initially logarithmic grow

152 such as galactose, cellobiose, lactose, and galactosyl-glycerol.

153 es of alpha-galactosidase A, and these alpha-galactosyl glycoconjugates were found in corneal keratoc

154 that VVH displays a preference for terminal galactosyl groups including N-acetyl-d-galactosamine and

155 ing of 3 with the peracetylated glucosyl and galactosyl halides 12a,b and 26 afforded, after saponifi

156 e 99m Tc diethylenetriamine pentaacetic acid-galactosyl-human serum albumin for evaluation of functio

157 Injection of biotinylated galactosyl-human serum albumin reduced the circulating l

158 and a decrease in hydroxylysine and glucosyl-galactosyl hydroxylysine.

159 the first-generation protocol, per-O-benzyl galactosyl iodide was efficiently coupled with activated

160 rence between the reactivity of glucosyl and galactosyl iodides.

161 ting that the recognition of the nonreducing galactosyl is essentially conserved, whereas the adjacen

162 ), mainly allolactose, 6-galactobiose and 6'-galactosyl lactose.

163 actose [Gal-beta(1 --> 6)-Glc] and 6'-O-beta-galactosyl-lactose [Gal-beta(1 --> 6)-Gal-beta(1 --> 4)-

164 thetic fluorescent acceptors with a terminal galactosyl, lactosyl or N-acetyl-lactosaminyl moiety.

165 Several glycosphingolipids, glucosyl-, galactosyl-, lactosyl-, and galabiosylceramide, were als

166 as -2.0-fold more active in forming 3'-alpha-galactosyl Lewis a than Lewis b.

167 ve in forming Lewis x, Lewis y, and 3'-alpha-galactosyl Lewis x, respectively.

168 GALS1 specifically formed beta-1,4-galactosyl linkages and could add successive beta-1,4-ga

169 an enzyme that hydrolyzes internal endo-beta-galactosyl linkages in keratan sulfate, and glycoconjuga

170 actomannan, BoMan26B generated a mixture of (galactosyl) manno-oligosaccharides shorter than mannohex

171 repeating phosphodisaccharide (consisting of galactosyl-mannose)) and LPG coincubated with LPG-neutra

172 A crystal structure of BoMan26B with galactosyl-mannotetraose bound in subsites -5 to -2 reve

173 The findings indicate that plants tailor galactosyl modification on glucomannans for constructing

174 Here, we show that fine-tuning of galactosyl modification on glucomannans is achieved by t

175 ccumulation of glycosphingolipids with alpha-galactosyl moieties consisting predominantly of globotri

176 ycosphingolipids that have terminal a-linked galactosyl moieties in vascular endothelial cells causes

177 a set of compounds bearing the glucosyl and galactosyl moieties.

178 nd volkensin was based on their affinity for galactosyl moieties.

179 ities, and in particular a compound having a galactosyl moiety at C-4 of the nonreducing GlcNAc moiet

180 tion coordinate involves the movement of the galactosyl moiety deep into the active site pocket.

181 n in lactose permease is directed toward the galactosyl moiety of lactose.

182 lts provide strong confirmation that the non-galactosyl moiety of permease substrates abuts Ala(122)

183 ative LT, LT(G33D) was unable to bind to the galactosyl moiety of Sepharose 4B or GM1 but did retain

184 e, Glu537, is seen to covalently bind to the galactosyl moiety.

185 ecific hydrophobic interactions with the non-galactosyl moiety.

186 (lyso-Gb3) by hydrolyzing the terminal alpha-galactosyl moiety.

187 bound to its putative ganglioside receptor, galactosyl-N-acetylgalactosaminyl (N-acetyl-neuraminyl)

188 ing that virolysis is mediated by anti-alpha-galactosyl natural Ab.

189 patic functional imaging study using [99mTc-]galactosyl-neoglycoalbumin (99mTc-NGA).

190 ith 99mTC-diethylenetriaminepentaacetic acid galactosyl-neoglycoalbumin.

191 receptor-binding radiopharmaceutical, 99mTc-galactosyl-neoglycoalbumin.

192 charge paired and form H-bonds with specific galactosyl OH groups.

193 C-4 GlcNAc hydroxyl group versus that of the galactosyl OH-3 in the selective glycosylation of a tris

194 of extrusion on bioactive compounds (sucrose-galactosyl oligosaccharides, insoluble dietary fibre, re

195 scoveries of plant enzymes that add specific galactosyl or acetyl decorations.

196 lpha2-->1 Sph, other lyso-phospholipids, and galactosyl- or lactosyl-Sph did not block such adhesion,

197 )-galactosidic linkage was installed using a galactosyl phosphate donor with high selectivity.

198 The galactosyl pyranose motif therefore offers many opportun

199 d FUT2, a pair of GDP-L-fucose:beta(1-->4)-D-galactosyl-R 2-alpha-L-fucosyltransferase enzymes (EC 2.

200 Linkage analysis of galactosyl residue by methylation, liquid secondary ion,

201 it preferentially to the 2-O-position of the galactosyl residue closest to the reducing end of the re

202 rbing the hydrophobic alpha face of the beta-galactosyl residue leads to complete loss of binding to

203 tional Kdo residue is attached to O-6 of the galactosyl residue of 1.

204 p of glycerol and to the 6-hydroxyl group of galactosyl residue of beta-galactosyl 1-->1 sphingosine

205 The terminal galactosyl residue of one branch of the triantennary oli

206 (r) Fucosylation by alpha 1,2-L-FT of the galactosyl residue which occurs on the antennary structu

207 of which lacks the Kdo linked to O-6 of the galactosyl residue, another that lacks the galacturonic

208 osaminyl or, alternatively, a terminal alpha-galactosyl residue.

209 of neutral sphingolipids with terminal alpha-galactosyl residues and subsequent accumulation in sever

210 rush borders, with both sialic acid and beta-galactosyl residues apparently involved.

211 suggest that N-linked glycans with terminal galactosyl residues facilitate cell surface binding and

212 ty to hydrolyze terminal, nonreducing beta-D-galactosyl residues from beta-D-galactosides.

213 ty was confirmed via a quantified release of galactosyl residues from cell wall fractions containing

214 SFR2 processively transfers galactosyl residues from the abundant monogalactolipid t

215 ses associated with these membranes transfer galactosyl residues from UDP-Gal to diacylglycerol.

216 Galactosyl residues had slightly higher levels of O-acet

217 ts glycan antennae bear terminal nonreducing galactosyl residues in alpha1-3 linkage.

218 oes not indiscriminately fucosylate terminal galactosyl residues in complex-type N-glycans, but it fa

219 lation of material containing terminal alpha-galactosyl residues in cultured embryonic fibroblasts de

220 iae that bind to two receptors: beta1-linked galactosyl residues in glycosphingolipids and the phosph

221 -deutero-methylation analysis indicated that galactosyl residues in the polysaccharide backbone are 3

222 lpha face that is uniquely displayed by beta-galactosyl residues is essential to the recognition of t

223 The presence of subtending galactosyl residues markedly enhance the activities of X

224 de A and Amide I in blood serum, and alpha-D-galactosyl residues of glycosphingolipids in urine.

225 fers beta1,6-linked GlcNAc preferentially to galactosyl residues of N-acetyllactosamine close to nonr

226 ansfer of fucose from GDP-fucose to terminal galactosyl residues on xyloglucan side chains.

227 orescent-labeled lectin specific for alpha-D-galactosyl residues showed accumulation of substrate in

228 ntly more radiolabel from [2-(3)H]Man into L-galactosyl residues suggesting that the mutation increas

229 ulate glycosphingolipids with terminal alpha-galactosyl residues that come from intracellular synthes

230 l linkages and could add successive beta-1,4-galactosyl residues to the acceptor.

231 esent multivalent sialylated and/or sulfated galactosyl residues under the conditions of the binding

232 de chains vary in length from one to over 20 galactosyl residues, and they are partly substituted wit

233 beta-GlcNAc are substituted with two and one galactosyl residues, respectively.

234 pha-1,3-linked 4,6-O-(1-carboxyethylidene)-D-galactosyl residues.

235 most part to changes in expression of alpha-galactosyl residues.

236 4-mannan backbone substituted with alpha-1,6-galactosyl residues.

237 ed with single-unit (1 --> 6)-alpha-linked D-galactosyl residues.

238 ate, 4-p-coumaroylquinic acid, quercetin-3-O-galactosyl-rhamnosyl-glucoside, kaempferol-3-O-glucosyl-

239 icularly for those acting on arabinosyl- and galactosyl-rich pectin side chains.

240 g: Cys148 hydrophobically interacts with the galactosyl ring, while Glu126 and Arg144 are charge pair

241 Nuclear imaging techniques ((99m)Tc-galactosyl serum albumin scintigraphy and (99m)Tc-mebrof

242 of replicating promastigotes is mediated by galactosyl side chain (scGal) modifications of phosphogl

243 f a conserved alpha-L-fucosyl-(1-->2)-beta-D-galactosyl side chain and excessive galactosylation at a

244 ys-149 in the -4 subsite interacted with the galactosyl side-group of the ligand.

245 compounds such as lyso-phosphatidylcholine, galactosyl-Sph (psychosine), and lactosyl-Sph at 0.5-10

246 leads to a progressive accumulation of some galactosyl-sphingolipids in the brain.

247 hesized that the accumulation of psychosine (galactosyl-sphingosine) in the TWI CNS may result in the

248 s the synthesis of galactosyl-alpha-1,3-beta-galactosyl structures in mammalian glycoconjugates.

249 nes and Staphylococcus aureus) or containing galactosyl substituents (those of Listeria spp. and Lact

250 The statistical distribution of galactosyl substituents along the mannan backbone, and t

251 ivity on galactomannan with a high degree of galactosyl substitution and was shown to be endo-acting

252 26 epitope has been identified as a beta-1,6-galactosyl substitution of beta-1,4-galactan requiring m

253 ctosyltransferase, MUR3, but is required for galactosyl-substitution of xyloglucan at a different pos

254 annan backbones acquire variable patterns of galactosyl substitutions, depending on plant development

255 these piglets had markedly reduced alpha 1,3 galactosyl sugar epitopes.

256 idase-treated Lfs lacked detectable terminal galactosyl sugars.

257 e laminin binding to collagen IV, to bind to galactosyl sulfatide, and to selectively convert alpha-s

258 We now show that SC expression of galactosyl-sulfatide, a Lm-binding glycolipid, precedes

259 ination of affinity chromatography on beta-D-galactosyl-Synsorb and ion-exchange chromatography on DE

260 icity of galectin-1 for eight different beta-galactosyl terminal disaccharides was studied using mole

261 ciency leads to impaired catabolism of alpha-galactosyl-terminal lipids such as globotriaosylceramide

262 ; EC ) leads to impaired catabolism of alpha-galactosyl-terminal lipids such as globotriaosylceramide

263 lectin activity of the protein toward beta1-galactosyl-terminated glycoconjugates.

264 ctin-like activity in interacting with beta1-galactosyl-terminated glycoconjugates.

265 Asialofetuin, the beta1-galactosyl-terminated glycoprotein inhibitor of VCC-indu

266 the full chemical affinity of azide ion for galactosyl transfer from the mutant enzyme which lacks t

267 presents the requirement for the coupling of galactosyl transfer from the native enzyme to the thermo

268 m the galactosyl-enzyme intermediates of the galactosyl transfer reactions catalyzed by E461G and E46

269 ignificant prolongation of heterotopic alpha Galactosyl transferase "knock-out" and human CD46 transg

270 e biosynthetic enzyme UDP-galactose:ceramide galactosyl transferase (CGT) are incapable of synthesizi

271 Mycobacterium tuberculosis being a putative galactosyl transferase (GalTr) implicated in galactan sy

272 o modify the porcine gene encoding alpha 1,3 galactosyl transferase (GGTA1).

273 nces of a rat sialyl transferase and a human galactosyl transferase along with the Arabidopsis homolo

274 s were transduced with an exogenous alpha1-3-galactosyl transferase gene, which codes for the termina

275 We also show that the activity of galactosyl transferase II (GalT-II, B3GalT6), a key enzy

276 Galactosyl transferase knock-out pig lungs fail rapidly

277 sing human serum on wild-type (WT) and alpha-galactosyl transferase knockout (GalTKO)/hCD46-transgeni

278 By using alpha-galactosyl transferase knockout (GT-/-) mice, which make

279 osphorylcholine (ChoP), and lic2, a putative galactosyl transferase that adds the terminal galactose

280 osyl transferase A (pgtA), which encodes the galactosyl transferase that catalyzes the synthesis of t

281 mutants, we found that lgtE, which encodes a galactosyl transferase that is required for elongating t

282 -like protein 2, alpha-lactalbumin, beta-1,4-galactosyl transferase, and poly-Ig (immunoglobulin) rec

283 s have been generated that possess disrupted galactosyl-transferase (GGTA1) genes.

284 a lepidopteran insect cDNA encoding a beta4-galactosyl-transferase family member.

285 intermediate is extended by two bifunctional galactosyl transferases, GlfT1 and GlfT2, and then it is

286 Arabidopsis encode XyG-specific fucosyl and galactosyl transferases, respectively.

287 The AGP-unreactive alpha-galactosyl Yariv reagent (alpha GalY) had no biological